• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC DOMINICANA DELTA VALVE, SMALL, PERFORMANCE LEVEL 1.0; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC DOMINICANA DELTA VALVE, SMALL, PERFORMANCE LEVEL 1.0; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 42812
Medical Device Problem Codes Infusion or Flow Problem (2964); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Headache (1880); Insufficient Information (4580)
Date of Event 12/05/2023
Type of Reportable Event Serious Injury
Event or Problem Description
Medtronic received information regarding a valve.It was reported that the patient was experiencing symptoms.The valve was replaced.The patient's status at the time of the report was alive-no injury.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information received reported that the patient underwent shunt placement back in (b)(6) 2023 and did very well for about 2 month but then subsequently had a valve malfunction for which they underwent valve replacement and then developed what the doctor figured were low-pressure headaches.The patient came in for diagnostic testing in the fall and early winter of 2023 with a working shunt.However, they had severe headaches and underwent placement of a right external ventricular drain at that time.Despite their ventricles being on the plumper side, their intracranial pressures at that time were low, and they did better with the external ventricular drain set at a higher setting and an abdominal binder.Thus, the patient was taken in the winter for a valve replacement in which their valve with pressure level 1.0 was changed out to a valve with a pressure level 1.5.
 
Additional Manufacturer Narrative
H3.Product analysis determined that the returned device was patent.The valve passed requirements for reflux, leakage and pressure flow/preimplantation testing.No signs of damage or debris were observed on/inside the valve.The distal end of the connector appeared bent, but it did not lead to any failure in flow through the valve or other characteristics tested.The laboratory personnel could not replicate the failure condition of obstruction as observed in the field.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTA VALVE, SMALL, PERFORMANCE LEVEL 1.0
Common Device Name
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC DOMINICANA
zona franca de san isidro
carretera san isidro, km 17
santo domingo 11500
DR  11500
Manufacturer (Section G)
MEDTRONIC DOMINICANA
zona franca de san isidro
carretera san isidro, km 17
santo domingo 11500
DR   11500
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key18485908
Report Number9612501-2024-00110
Device Sequence Number9133920
Product Code JXG
UDI-Device Identifier00763000028374
UDI-Public00763000028374
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
K902783
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number42812
Device Catalogue Number42812
Device Lot Number0223355058
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/09/2024
Supplement Date Received by Manufacturer03/13/2024
03/22/2024
Initial Report FDA Received Date01/10/2024
Supplement Report FDA Received Date03/20/2024
03/25/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/13/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-